UPDATE: Merck KGaA, Pfizer (PFE) to Terminate JAVELIN Ovarian 100 Trial of Avelumab
Tweet Send to a Friend
(Updated - December 21, 2018 2:06 PM EST)
Merck KGaA, Darmstadt, Germany, and Pfizer Inc. (NYSE: PFE) today announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Merck KGaA, Darmstadt, Germany, and Pfizer Inc. (NYSE: PFE) today announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
